MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
about
TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport.Total syntheses of the archazolids: an emerging class of novel anticancer drugs.Re-expression of the p53 Gene by Inhibiting the Mdm-2 Receptor in Wild-type p53 Tumors for the Treatment of Glioblastoma: A Mini Review
P2860
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
@en
type
label
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
@en
prefLabel
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
@en
P2093
P2860
P1433
P1476
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
@en
P2093
Dirk Menche
Karin von Schwarzenberg
Lina S Schneider
Melanie Ulrich
Thorsten Lehr
P2860
P304
P356
10.1016/J.MOLONC.2016.04.005
P50
P577
2016-04-27T00:00:00Z